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RIP1 is an adaptor kinase originally identified as being able to associate with TNFR1
and Fas, and is later shown to be involved in signaling induced by TLRs. Major signaling
pathways regulated by RIP1 include necroptosis, apoptosis, and pro-survival/inflammation
NF-κB activation. Previous studies show that RIP1 deficiency has no effect on mouse
embryogenesis, but blocks postnatal development. This phenotype could not readily be
explained, since mice lacking TNFR1, Fas, or TLRs show no apparent developmental
defect. Certain types of RIP1-deficient cells are hypersensitive to TNF-induced apoptosis.
However, in our previous study, deletion of the apoptotic adaptor protein, FADD, provides
marginal improvement of postnatal development of rip1−/− mice. Remarkably, the
current data shows that haploid insufficiency of RIP3, a known mediator of necroptosis,
allowed survival of rip1−/−fadd−/− mice beyond weaning age, although the resulting
rip1−/−fadd−/− rip3+/− mice were significant smaller in size and weight. Moreover,
complete absence of RIP3 further improved postnatal development of the resulting
rip1−/−fadd−/−rip3−/− mice, which display normal size and weight. In such triple knockout
(TKO) mice, lymphocytes underwent normal development, but progressively accumulated
as mice age. This lymphoproliferative (lpr ) disease in TKO mice is, however, less severe
than that of fadd−/−rip3−/− double knockout mice. In total, the data show that the
postnatal developmental defect in rip1−/− mice is due in part to FADD-mediated apoptosis
as well as RIP3-dependent necroptosis. Moreover, the function of RIP1 contributes to
development of lpr diseases.
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INTRODUCTION
Apoptosis and necroptosis are programmed cell death (PCD)
pathways that play an essential role during animal develop-
ment and immune responses (Moriwaki and Chan, 2013; Walsh,
2014). Although these two PCD pathways have distinct mecha-
nisms and outcomes, they are intricately connected and, there-
fore, must be tightly regulated. PCD can be initiated through
the death receptors (DRs) like Fas and tumor necrosis fac-
tor receptor-1 (TNFR1) (Ashkenazi and Dixit, 1998). Apoptotic
death induced by DRs is mediated by the Fas-associated death
domain (FADD or MORT1) adaptor protein (Boldin et al.,
1995; Chinnaiyan et al., 1995; Zhang and Winoto, 1996). FADD
binds to and activates the apical Caspase 8, which then cleaves
and activates the effector Caspases, and triggers the apoptotic
program (Boldin et al., 1996; Muzio et al., 1996). When apop-
totic pathway is blocked, such as through viral defense mech-
anisms or Caspase inhibitory conditions, DRs signaling could
lead to necroptosis which is mediated through the receptor
interacting protein (RIP)1-RIP3-mixed lineage kinase domain-
like (MLKL) protein axis (Holler et al., 2000; Degterev and
Yuan, 2008; Cho et al., 2009; Sun et al., 2012; Zhao et al.,
2012).
One striking example of the importance of these PCD path-
ways in immune homeostasis is illustrated by a mutant mouse
strain with lymphoproliferative (lpr) disease caused by mutations
in the fas gene (Strasser et al., 2009). In lpr mice, lymphocytes are
unable to undergo Fas-mediated cell death, leading to accumu-
lation of a unique subset of T cells that lose expression of CD4
and CD8 and gain expression of B220, a traditional B cell marker
(Strasser et al., 2009). Moreover, in certain genetic backgrounds,
the lpr Fas mutation facilitates autoimmunity including glomeru-
lonephritis, arthritis, and autoantibody production, and diseases
sharing symptoms of systemic lupus erythematosus (SLE) (Cohen
and Eisenberg, 1992; Shi et al., 2002). In human patients contain-
ing mutations in the fas gene, a similar disease has been identified
as autoimmune-lymphoproliferative symdrome (ALPS) (Fisher
et al., 1995). Deletion of TNFR1 alone does not affect lym-
phoid homeostasis (Pfeffer et al., 1993; Rothe et al., 1993), but
exacerbates the lpr disease of Fas mutant mice (Zhou et al., 1996).
Besides abnormality in certain immune functions, mice lack-
ing each individual DR undergo normal embryogenesis and post-
natal development in mice (Pfeffer et al., 1993; Rothe et al., 1993;
Adachi et al., 1996; Diehl et al., 2004). Surprisingly, inactivation
of FADD, the common signaling adaptor of the DRs, results in
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death around embryonic day (E)11.5 (Yeh et al., 1998; Zhang
et al., 1998). It has been demonstrated that fadd−/− embryos con-
tain elevated levels of RIP1 and undergo massive necrosis (Zhang
et al., 2011). Lack of RIP1 completely corrects the embryonic
defect in fadd−/− embryos. Moreover, RIP3 deletion prevents T
cell death induced by expression of a FADD dominant-negative
(DN) mutant (Lu et al., 2011). Unlike RIP1, RIP3 does not play
a role in NF-κB activation (Newton et al., 2004). Deletion of
RIP3 completely restores normal development of mice lacking
FADD or Caspase 8 (Ch’en et al., 2011; Kaiser et al., 2011; Oberst
et al., 2011), indicating that RIP1/RIP3-dependent necroptosis is
unleashed in the absence of FADD or Caspase 8.
Though RIP1 was initially identified as a Fas-binding protein
(Stanger et al., 1995), apoptosis through Fas is not affected in
rip1−/− cells (Ting et al., 1996; Kelliher et al., 1998). However,
RIP1 deficiency leads to hypersensitivity to TNF-induced apop-
tosis, which has been attributed in part to a defect in NF-κB acti-
vation in certain cell types. When signaling through receptors like
TNFR1 or toll like receptors (TLRs), the ubiquitination status of
RIP1 can determine whether a cell lives or dies (Vucic et al., 2011;
Schmukle and Walczak, 2012). For example, upon activation of
TNFR1, RIP1 promotes NF-κB activation when ubiquitinated,
but mediates apoptosis when deubiquitinated and associated with
FADD and Caspase 8. Furthermore, if the function of FADD or
Caspase 8 is interrupted, RIP1 kinase activity signals through
RIP3, leading to necroptosis (Moriwaki and Chan, 2013; Vanden
Berghe et al., 2014). These multiple functions of RIP1 partici-
pate in regulating inflammatory signaling and have been a target
of interest for inflammatory disease (Moriwaki and Chan, 2013;
Vanden Berghe et al., 2014; Walsh, 2014).
The importance of RIP1 during development is manifested in
rip1−/− mice, which die at birth with extensive cell death in the
lymphoid and adipose tissues (Kelliher et al., 1998) Since with-
out RIP1, TNFR1 initiates FADD-mediated apoptosis (Cusson
et al., 2002; O’Donnell and Ting, 2011), it was surprising that
deletion of FADD does not rescue rip1−/− mice from perinatal
lethality (Zhang et al., 2011). This suggests that RIP1 could play
different roles during embryonic development, where it may ini-
tiate necroptosis in the absence of FADD, and in perinatal mice,
where RIP1 is essential for survival. Unlike perinatal lethality in
rip1−/− or rip1−/−fadd−/− mice, normal embryonic and post-
natal development is observed in fadd−/−rip3−/− mice (Dillon
et al., 2012). Moreover, under certain circumstances, RIP3 is able
to signal necroptosis in the absence of RIP1 (Upton et al., 2010;
Moujalled et al., 2013). In this study, we performedmouse genetic
studies and show that lack of RIP3 is insufficient to correct the
defect in RIP1 mice. However, the resulting rip1−/−rip3−/− mice
could survive to adulthood if FADD is also inactivated. Therefore,
our data indicate that RIP1 has a novel function, which appears
to provide protection against RIP3-dependent necroptosis and
FADD-mediated apoptosis during postnatal development.
MATERIALS AND METHODS
MICE
fadd+/− mice have been previously described (Zhang et al., 1998).
rip1+/− mice were provided by Dr. Michelle Kelliher (Kelliher
et al., 1998). rip3−/− mice were provided by Drs. Kim Newton
and Vishva Dixit (Genentech) (Newton et al., 2004). All animal
studies were approved by the Institutional Animal Care and Use
Committee (IACUC) at Thomas Jefferson University.
MOUSE GENETIC ANALYSIS
rip1+/−fadd+/− mice were crossed with rip3−/− mice. The result-
ing rip1+/−fadd+/−rip3+/− triple heterozygous (THZ) mice
were intercrossed. From the offspring, rip1+/−fadd−/−rip3−/−
mice were mated with THZ mice, producing viable and fer-
tile rip1−/−fadd−/−rip3−/− triple knockout (TKO) mice, which
were mated with rip1+/−fadd−/−rip3−/− mice. For genotyp-
ing, genomic DNA was isolated from the tails of newborns to
weaning-age mice using proteinase K and sodium dodecyl sul-
fate (SDS)-containing lysis buffer followed by phenol extraction
and ethanol precipitation. Allele-specific primers were used to
detect the presence of wild type and knockout alleles of rip1
and fadd as previously described (Zhang et al., 2011). rip3−/−
mice were typed using the forward primers 5′-GCCTGCCC
ATCAGCAACT-3′ and 5′-CCAGAGGCCACTTGTGTAGCG-3′
and reverse primer 5′-CGCTTTAGAAGCCTTCAGGTTGAC-3′
(Newton et al., 2004). PCR produces a 320 bp wild type band and
a 485 bp knockout band. For postnatal survival analysis, neonates
were monitored for survival from birth to weaning age; deceased
pups were immediately collected and genotyped. Survival curves
were generated using Prism software (Graphpad Software, Inc.).
For genetic analysis, the numbers of mice containing the most
numbers of wild type alleles of the genes of concern were used
to predict the numbers of other genotypes among the offspring of
the indicated crosses, based on Mendelian ratios.
WESTERN BLOTTING ANALYSIS
The presence or absence of FADD, RIP3, and RIP1 protein was
confirmed by western blotting. Total splenocytes were isolated
from mice of the indicated genotypes. Cell lysates were pre-
pared in cold RIPA lysis buffer containing 50mM Tris pH 8.0,
150mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS,
1mM phenylmethyl sulphonyl fluoride (PMSF), and a proteinase
inhibitor cocktail (Roche). Proteins (30μg) were separated on
a 10% SDS-PAGE gel and transferred to a nitrocellulose mem-
brane. Proteins on the membrane were stained with Ponceau S
(Sigma-Aldrich) as a loading/transfer control. Antibodies specific
for FADD (generated in house), RIP3 (ProSci, Catalog #2283),
and RIP1 (BD Biosciences, Catalog #610459) were incubated with
the membrane overnight at 4◦C followed by HRP-conjugated
goat anti-rabbit antibodies (1/10,000). Chemiluminescent signals
were detected on the ProteinSimple FluorChemM Western Blot
Imaging machine.
FLOW CYTOMETRIC ANALYSIS
Spleen, lymph nodes, and thymus of mice were isolated during
mouse dissection. Red blood cell lysis of the spleen was performed
using ACK buffer and single cell suspensions were prepared. Cells
(106) were stained with fluorochrome-conjugated antibodies in
PBS containing 3%BSA, 0.5mMEDTA, and 0.05% sodium azide,
and samples were incubated on ice for 30min. Antibodies used
for flow cytometry were anti-CD3 (BD Biosciences), anti-CD4
(Caltag), anti-CD8 (Invitrogen), and anti-B220 (BD Biosciences).
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Data were acquired on an LSR II cytometric analyzer (BD
Biosciences) and analyzed using FlowJo software (TreeStar).
CELL CULTURE
Thymocytes and peripheral T cells purified from the spleen and
lymph nodes were cultured in complete RPMI media (cRPMI)
containing 10% FBS, 2mM L-Glutamine, penicillin (100 U/mL),
streptomycin (100μg/mL), and β-mercaptoethanol (50μM).
TOTAL CELLULARITY CALCULATIONS
Total cell number was obtained using single cell suspensions
spleen and lymph nodes counted using a Countess Automated
Cell Counter (Invitrogen). Cell number of various lymphocyte
subsets was obtained by multiplying the total cell number with
percentages of subsets of CD3+ and B220+ cells obtained by flow
cytometry.
CELL DEATH ASSAYS
Thymocytes (105) were seeded in a 96-well flat-bottom plate in
100μL of cRPMI and incubated at 37◦C with 5% CO2for 16 h
with indicated concentrations of anti-Fas antibodies, TNFα, or
dexamethasone. Thymocytes were also incubated with no treat-
ment, staurosporine (1μg/mL), and ionomycin (1μg/mL) for
indicated time points. Cells were collected, each well was washed
with PBS, and 1μg/mL propidium iodide was added to the
sample. Cells were analyzed by flow cytometry on an LSR II cyto-
metric analyzer (BD Biosciences). In some cases, Percent Specific
Death was calculated by: (percent cell killing with treatment)—
(percent cell killing without treatment).
PROLIFERATION ASSAYS
T cells were purified by pooling total spleen and lymph node cells
of five-week-old mice and using antibodies against Thy1.2 and
B220. Thy1.2+B220− T cells were sorting using a FACS Aria (BD
Biosciences). Purified T cells were labeled with CellTrace Violet
(Life Technologies), as per the manufacturer’s instructions. Cells
were placed in a 96 well round-bottom plate (2 × 105 cells/well)
and stimulated with 1μg/mL anti-CD3 antibody and 0.2μg/mL
anti-CD28 antibody in 100μL cRPMI for various timepoints.
Cells were stained with 1μg/mL propidium iodide and run on an
LSR II cytometric analyzer (BD Biosciences). For 3H-thymidine
experiments, cells were placed in a 96 well round-bottom plate
(105 cells/well) and stimulated with 1μg/mL anti-CD3 antibody
and 0.2μg/mL anti-CD28 antibody for 40 h. Two microcuries
of tridiated thymidine were added to each well and cells were
FIGURE 1 | rip1−/− perinatal lethality ismediated by FADD and RIP3. (A–C)
Predicted and actual frequency of indicated genotypes of weaning age mice
resulting from intercrosses of rip1+/−fadd+/−rip3+/− THZ mice (A), crosses
of rip1+/−fadd+/−rip3+/− and rip1+/−fadd−/−rip3−/− mice (B), and crosses
of rip1+/−fadd−/−rip3−/− and rip1−/−fadd−/−rip3−/− mice (C). (D) Survival of
newborn mice from various intercrosses. For this and following figures, control
mice are littermates that have at least one wild type allele of FADD and RIP1.
The fadd−/−rip3−/− mice shown contain at least one wild type allele of rip1.
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incubated for an additional 8 h. Samples were placed onto a glass
fiber filter using a Mach Harvester 96 (Tomtec) and analyzed
using a Wallac 1205 Betaplate Counter (Perkin Elmer).
STATISTICAL ANALYSIS
Data is expressed as mean ± standard deviation. Student’s t-tests
were performed using Prism software (Graphpad Software, Inc).
RESULTS
POSTNATAL DEVELOPMENT OF rip1−/− MICE IN THE ABSENCE OF
RIP3 AND/OR FADD
To determine whether RIP3 plays a role in the postnatal defect
of rip1−/− mice, rip1+/−rip3+/− or rip1+/−rip3−/− mice
were intercrossed, which produced no viable rip1−/−rip3−/−
double knockout (DKO) or rip1−/−rip3+/− mice at wean-
ing age (data not shown). This observation was confirmed
when rip1+/−fadd+/−rip3+/− triple heterozygous (THZ)
mutant mice were intercrossed, which produced no viable
rip1−/−rip3−/− mice containing one or both alleles of FADD,
though Mendelian genetics predicts 12 mice of such genotypes
(column 5, Figure 1A). Nonetheless, rip1−/−rip3−/− newborns
were detected, and showed slightly improved survival up to
postpartum day (p)6, as compared to rip1−/− newborns which
died at p1 (Figure 1D). In contrast, if one or both alleles of the
rip1 gene were present, fadd−/−rip3−/− DKO mice were viable
from birth to adulthood (column 9, Figure 1A).
Similar to the previous study (Zhang et al., 2011), no viable
rip1−/−fadd−/− mice were present at weaning age among the
offspring of THZ intercrosses (column 7, Figure 1A). Strikingly,
however, absence of one allele of RIP3 allowed survival of
rip1−/−fadd−/− mice beyond weaning ages up to adulthood
(column 8, Figures 1A, 2A). Presence or absence of the FADD,
RIP1, and RIP3 proteins was analyzed by western blotting
(Figure 2B). These observations were also confirmed by anal-
ysis of the offspring from crosses of rip1+/−fadd−/−rip3−/−
mice with rip1+/−fadd+/−rip3+/− THZmice (Figure 1B), which
produce higher ratios of rip1−/−fadd−/−rip3+/− mice.
Further examination revealed that although
rip1−/−fadd−/−rip3+/− mice were viable, they were much
smaller in size (Figure 2A), and also weighed less than wild type
controls or fadd−/−rip3−/− mice during the indicated period of
analysis (Figure 2C). Moreover, rip1−/−fadd−/−rip3+/− mice
appeared to be present at lower numbers (2) at weaning age than
the predicted Mendelian frequencies (8) (column 8, Figure 1A).
FIGURE 2 | Haploid insufficiency of rip3 improves survival of
rip1−/−fadd−/− mice, which are viable but weigh less than wild
type controls. (A) Adult rip1−/−fadd−/−rip3+/− mouse and littermate
control. (B) Western blot analysis of total splenocytes confirming
presence or absence of FADD, RIP3, and RIP1 protein. (C) Weight
curves showing the rip1−/−fadd−/−rip3+/− mouse with age-matched
controls. Data shown is representative of three mice of each
genotype.
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Western blotting analysis indicated that ablation of one allele of
RIP3 resulted in lower RIP3 protein levels (Figure 2B), which
helped improve survival of rip1−/−fadd−/− mice.
Interestingly, when both alleles of RIP3 were absent, the
resulting rip1−/−fadd−/−rip3−/− triple knockout (TKO) mice
gained weight normally, as compared to wild type control or
fadd−/−rip3−/− DKO mice (Figures 1, 3A,C,D). Nonetheless,
the numbers of the TKO mice appeared to be lower than
that predicted by Mendelian ratios, particularly among the
offspring of the mouse cross in Figure 1B (column 10).
This defect is more pronounced through analyzing the off-
spring of crosses between rip1+/−fadd−/−rip3−/− mice and
TKO mice (Figure 1C). This correlates with decreased sur-
vival of rip1−/−fadd−/−rip3−/−mice from birth to weaning
age (Figure 1D). Knockout of these genes was confirmed by
western blotting (Figure 3B). In total, these data showed that
while rip1−/−rip3−/− mice did survive several days longer than
rip1−/−, knockout of both FADD and RIP3 was necessary for
survival of rip1−/− mice to adulthood.
THE ROLE OF RIP1, FADD, AND RIP3 IN LYMPHOCYTE RESPONSES
The role of these proteins in lymphocyte development and func-
tion has been previously investigated through gene deletion in
germ cells or in specific lineages. The lymphoid system of rip3−/−
mice is normal (Newton et al., 2004). Without FADD function,
peripheral T cell number decreases (Walsh et al., 1998; Zhang
et al., 2005), but the B cell compartment is normal (Imtiyaz
et al., 2006). Lastly, inducible deletion of RIP1 results in greatly
reduced lymphocyte numbers (Roderick et al., 2014). We ini-
tially analyzed young (4 week old) mice, due to concerns of
age-dependent diseases (see below). The fadd−/−rip3−/− DKO
and rip1−/−fadd−/−rip3−/− TKO mutant mice contained nor-
mal T cell populations in the thymus, similar to that in control
mice (Figure 4B). This indicates that RIP1 deficiency does not
affect T lymphocyte development, as long as FADD and RIP3 are
absent. The lymphoid organs of DKO and TKO mice at 5 weeks
of age were not significantly larger than control mice, and these
mutant mice appeared to contain higher numbers of B cells in the
lymph nodes (Figures 4A,C,D).
The extrinsic cell death pathways mediated by the DRs are
essential for immune homeostasis, as indicated by the lpr mouse
model. Disruption of FADD function blocks Fas-induced apop-
tosis in T cells (Walsh, 2014). We previously have shown that
absence of RIP1 has no effect on Fas-induced death, but leads
to hypersensitivity to TNF-induced death in thymocytes (Zhang
et al., 2011). In contrast, rip1−/−fadd−/− thymocytes were resis-
tant to TNF, similar to wild type thymocytes (Zhang et al.,
2011). In order to determine the status of these pathways
FIGURE 3 | Complete ablation of both RIP3 and FADD rescued rip1−/−
perinatal lethality. (A) rip1−/−fadd−/−rip3−/− mouse with fadd−/−rip3−/−
and littermate control. (B) Western blot of total splenocytes confirming
presence or absence of FADD, RIP3, and RIP1 protein. (C) Weight curves
of rip1−/−fadd−/−rip3−/− with age-matched controls, representative of at
least three mice of each genotype. (D) Body weight of 3- to 6-month-old
mice at time of analysis. Data shown is representative of four mice of
each genotype.
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FIGURE 4 | Young rip1−/−fadd−/−rip3−/− mice contain normal T and B
cell populations. (A,B) Spleen, lymph node, and thymus of 5 week old
mice of the indicated genotypes were stained with antibodies for CD3 and
(Continued)
FIGURE 4 | Continued
B220 (A) or CD4 and CD8 (B). Numbers indicated are percentages of
T cell and B cell subsets. (C) Lymph nodes, spleen, thymus of 5
week-old mice. (D) Weight of spleen and lymph node of mice 4–6
week old mice. ns, not significant. Data shown is representative of at
least three independent experiments with one mouse of each
genotype.
in rip1−/−fadd−/−rip3−/− mice, thymocytes were isolated and
treated with various stimuli to initiate extrinsic or intrinsic cell
death. Similar to fadd−/−rip3−/− DKO thymocytes, TKO thy-
mocytes were highly resistant to cell death responses induced
by Fas (Figure 5A). Unlike rip1−/− thymocytes (Zhang et al.,
2011), TKO and DKO mutant thymocytes were not sensitive to
TNFα-induced cell death (Figure 5B). However, they were able to
undergo intrinsic apoptosis in response to dexamethasone, simi-
lar to wild type thymocytes (Figure 5C). Furthermore, DKO and
TKO thymocytes were sensitive to staurosporine and ionomycin-
induced intrinsic apoptosis, as compared with untreated cells
(Figures 5D–F). These results imply that resistance to extrinsic
cell death is essential for the survival of rip1−/− mice.
Previous studies indicated that FADD is required during
lymphocyte proliferative responses, to sequester RIP1/RIP3-
dependent necrosis (Lu et al., 2011; Zhang et al., 2011). To ana-
lyze TCR-induced proliferation, peripheral T cells were isolated
and stimulated with anti-CD3 antibodies. In tritiated thymidine
incorporation assays, there appeared to be more proliferation in
fadd−/−rip3−/− T cells and rip1−/−fadd−/−rip3−/− T cells than
control T cells (Figure 6A). In further analysis, T cell division
kinetics and death responses were analyzed through two-color
flow cytometry. T cells were pre-labeled with the CellTrace dye,
and then stimulated with anti-CD3/CD28 antibodies. T cell
division is indicated by dilution of CellTrace, and cell death
measured through propidium iodide dye staining. As shown in
Figure 6B, accelerated proliferative responses were seen in both
fadd−/−rip3−/− and rip1−/−fadd−/−rip3−/− T cells, when com-
pared to control T cells. Moreover, there was less cell death in
DKO and TKOmutant T cells than in control T cells (Figure 6B).
THE ROLE OF RIP1 IN AGE-DEPENDENT lpr DISEASES
Previous studies have shown that disruption of the function
of FADD by using a FADD-DN mutant results in an lpr-like
symptom in aged rip3−/− mice (Lu et al., 2011). Similarly,
fadd−/−rip3−/− DKO mutant mice developed lpr-like symp-
toms including enlarged lymph nodes and spleen in as early
as 5-week old mice (Figure 7 and data not shown). As mice
age, the lymphadenopathy and splenomegaly phenotype become
more pronounced, as indicated by greatly increased size, weight,
and total cellularity of the secondary lymphoid organs of the
fadd−/−rip3−/− DKO mice (Figures 7A–C). Interestingly, these
signature lpr symptoms were diminished in TKO mice, as com-
pared to DKO mice (Figure 7).
Flow cytometric analyses showed that DKO mice contained
the unique subset of CD3+ T cells, which express the B cell
marker B220+, a signature phenotype of the Fas mutant mice
(Figure 8A). Furthermore, these T cells lose the expression of
CD4 and CD8 (Figure 8B). When absolute numbers of distinct
Frontiers in Cell and Developmental Biology | Cell Death and Survival February 2015 | Volume 3 | Article 12 | 6
Dowling et al. RIP1 in mouse development
FIGURE 5 | rip1−/−fadd−/−rip3−/− mice had impairment of extrinsic, but
not intrinsic, cell death pathways. (A–D) Thymocytes of indicated
genotypes were treated with various doses of (A) anti-Fas antibody, (B)
TNFα, (C) Dexamethasone and cell death was determined by PI uptake after
16 h incubation. (D–F) Thymocytes were treated with (D) staurosporin
(1μg/ml), (E) ionomycin (1μg/mL) or (F) no treatment for indicated time and
cell death was determined by PI uptake. Experiments were performed in
triplicate.
lymphocyte populations were determined, DKO mice aged 3–6
months were shown to accumulate dramatically higher numbers
of CD3+B220+ T cells (Figure 8C). Moreover, B cells and con-
ventional T cells (CD3+B220−) number also increased in DKO
mice (Figures 8D,E). Such lpr-like phenotypes were significantly
less severe when RIP1 was deleted (Figures 7, 8).
DISCUSSION
PCD is tightly controlled in order to ensure proper embry-
onic and postnatal development as well as to maintain tissue
homeostasis. Two major PCD pathways, intrinsic and extrinsic
apoptosis, have been well-studied. Intrinsic apoptosis is medi-
ated by pro-apoptotic members of the Bcl-2 family proteins
including Bax and Bak, which are counteracted by Bcl-2 and Bcl-
XS/L (Marsden and Strasser, 2003; Danial and Korsmeyer, 2004).
Absence of Bcl-XS/L blocks embryogenesis at early-midgestation
stages due to massive cell death, and deletion of Bcl-2 results
in lymphopenic conditions due to greatly increased apoptosis in
lymphocytes. In contrast, when proapoptotic Bim is inactivated,
mice develop autoimmune and lymphoproliferative diseases
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FIGURE 6 | Proliferative responses of TKO and DKO T cells are more
robust than control T cells. (A) T cells of indicated genotypes were
stimulated with anti-CD3, anti-CD28 antibodies. Proliferation was measured
by [3H]-thymidine incorporation (cpm, counts per minute). (B) T cells labeled
with CellTrace dye were stimulated with anti-CD3, anti-CD28 antibodies.
Dilution of CellTrace dye and uptake of propidium iodide was monitored by
flow cytometry at various time points. Data shown is representative of at
least three independent experiments with one mouse of each genotype.
(Bouillet et al., 2002). The significance of extrinsic PCD path-
ways during animal development mediated by DRs or TLRs has
been underappreciated, mainly because mice lacking these recep-
tors undergo normal embryonic and postnatal development. As
such, developmental defects in mice without the downstream
signaling proteins of the DRs, including RIP1, FADD, Caspase
8, or cFLIP, remained largely a conundrum for over a decade,
until a latent, RIP1/RIP3-dependent necrosis-like death pathway
FIGURE 7 | Lymphadenopathy and splenomegaly is less severe in TKO
mice, compared to DKO mice. (A) Thymus, lymph nodes, and spleen of
6-month-old mice (B) Weight of spleen and lymph nodes of mice >3
months old (C) Total cell number of spleen and lymph node of mice 3–6.5
months old. At least five mice from each group were used to generate
given data. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, not significant.
has been revealed recently (Moriwaki and Chan, 2013; Walsh,
2014).
The fact that RIP1, as implicated in studies based on cell sys-
tems, is involved in the regulation of NF-κB activation, apoptosis,
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FIGURE 8 | Knockout of RIP1 reduced severity of the lpr symptoms of
lymphadenopathy and splenomegaly in fadd−/−rip3−/−. (A,B) Spleen,
lymph node, and thymus of six-month-old mice of the indicated genotypes
were stained with antibodies for CD3 and B220 (A) or for CD4 and CD8 (B).
Numbers indicated are percentages of T cell and B cell subsets. (C–E) Scatter
plots of total number of (C) CD3+B220+ T Cells, (D) B cells, and (E)
conventional CD3+B220− T cells. At least fivemice from each groupwere used
to generate given data. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, not significant.
and necroptosis, poses as a challenge in understanding the peri-
natal lethality phenotype of rip1−/− mice (Kelliher et al., 1998).
One possible mechanism is that rip1−/− cells become hypersen-
sitive to extrinsic cell death, as observed previously(Ting et al.,
1996; Kelliher et al., 1998). However, our previous study shows
that blocking extrinsic apoptosis pathways alone through deletion
of FADD is insufficient, as postnatal survival of rip1−/−fadd−/−
mice were only marginally improved (Zhang et al., 2011).
Alternatively, evidence exists, which implies that RIP3 mediates
necroptosis in the absence of RIP1 (Upton et al., 2010; Moujalled
et al., 2013). Indeed, we found that deletion of RIP3 helped
improve the survival of rip1−/− mice for several additional days
(Figure 1 and data not shown). Importantly, the current study
demonstrates that postnatal lethality in rip1−/− mice is due to the
functions of not only FADD but also RIP3, because rip1−/− mice
could reach adulthood only if both the FADD and RIP3 genes
are ablated simultaneously (Figures 1–3). Firstly, decreasing the
RIP3 protein level through deletion of just one allele of the RIP3
gene significantly improved survival of rip1−/−fadd−/−, although
the resulting rip1−/−fadd−/−rip3+/− mice had trouble gaining
weight (Figures 1, 2). This could suggest that the initial pathology
of cell death in the adipose tissue rip1−/− mice is partially medi-
ated by RIP3, which may explain the systemic inflammation dis-
played in rip1−/−fadd−/−rip3+/− mice, as indicated in a previous
independent study (Kaiser et al., 2014). Secondly, when both alle-
les of RIP3 were deleted, the resulting TKOmice show no defect in
body sizes and weights as compared to DKO or control littermates
(Figure 3). This data implies that during postnatal development,
rip1−/− cells may undergo both FADD-mediated apoptosis and
RIP3-dependent necroptosis. This new finding is counterintu-
itive because RIP1 appears to signal through RIP3 in promoting
necroptosis in embryonic cells lacking FADD or Caspase 8 or
cFLIP (Kaiser et al., 2011; Oberst et al., 2011; Dillon et al., 2012).
In particular, our previous study showed that deletion of the
RIP1 adaptor kinase is able to correct the embryonic defect in
fadd−/− mice (Zhang et al., 2011). Moreover, fadd−/− or caspase
8−/− mice could reach adulthood when RIP3 is deleted (Kaiser
et al., 2011; Oberst et al., 2011; Dillon et al., 2012). It appears
that RIP1 plays distinct roles at different stages during develop-
ment. While dispensable in embryos, RIP1 is required to restrict
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FADD-mediated apoptosis and RIP3-dependent necroptosis in
order to ensure proper postnatal development.
The precise mechanism involved in RIP1-mediated sequestra-
tion of apoptosis and necroptosis remains to be further defined.
One scenario involves cFLIP, an inhibitor of both apoptosis and
necroptosis. cFLIP is a target of NF-κB (Kreuz et al., 2001), which
could be activated through RIP1 under certain circumstances.
Likely, lack of RIP1 impairs the expression of cFLIP. It was pre-
viously thought that the defect in rip1−/− mice is due, in part,
to TNFR1-triggered apoptosis. Recently, deletion of TNFR1 or
caspase 8 in addition to RIP1 was attempted to mitigate uncon-
trolled apoptosis, but provided no survival advantage (Rickard
et al., 2014). A RIP1-independent necroptotic pathway is induced
by TLR3 and TLR4 through its adaptor TIR-domain-containing
adaptor-inducing interferon-β (TRIF), which can bind RIP3 via
the RIP homotypic interaction motif (RHIM) (Kaiser et al., 2013;
Dillon et al., 2014). These two TLRs could also trigger activa-
tion of NF-κB through RIP1 (Meylan et al., 2004; Zhang et al.,
2011). The type I and type II interferon (IFN) receptors are also
capable of inducing necroptosis (Balachandran et al., 2004; Kaiser
et al., 2014). In concordance with these models, knockout of TRIF
or the type I IFN receptor, in addition to knockout of RIP1 and
TNFR, modestly prolonged survival, allowing a small number of
these mice to survive to weaning age (Dillon et al., 2014). The
perinatal lethality of rip1−/− mice was partially rescued when
apoptosis or necroptosis mediated by TNFR, TLRs, or IFN recep-
tors was blunted (Dillon et al., 2014; Kaiser et al., 2014; Rickard
et al., 2014).
RIP3 and MLKL have been shown to execute necroptosis in
a RIP1-independent manner through Toll-like Receptor-3 (TLR-
3) (Upton et al., 2010; He et al., 2011; Kaiser et al., 2013).
Recent independent study has shown that ablation of either
RIP3 or MLKL in addition to RIP1 resulted in lower levels
of cleaved caspase 3 in various organs in newborns compared
with rip1−/− newborns as well as lower levels of inflammatory
cytokines, potentially due to lower levels of damage-associated
molecular patterns (DAMPs) released fromnecrotic cells (Rickard
et al., 2014). However, these mice did not survive past day p4.
Another study found that a small percentage of rip1−/−rip3−/−
mice survived up to 21 days, however, we see no survival of
rip1−/−rip3−/− mice beyond day p6 (Figure 1D). Furthermore,
some rip1−/−tnfr−/− survived for 18 days (Dillon et al., 2014),
whereas such mice die right at birth in a separate study (Rickard
et al., 2014). Combined knockout of RIP3 and TNFR1 did allow
survival of rip1−/− mice into adulthood, but these mice ulti-
mately succumbed to blood bacteremia, sepsis, and prevalent
apoptosis in the intestines (Dillon et al., 2014). This lethal intesti-
nal defect caused by RIP1 ablation that was recently characterized
using cell-specific Cre-mediated deletion of RIP1 (Dannappel
et al., 2014; Takahashi et al., 2014). In another study, it was
noted that rip1−/−rip3−/−tnf−/− mice did not survive past day
28 (Kaiser et al., 2014). The discrepancy in survival of mice in
these studies could be due to differences in genetic backgrounds
of the mice used. The lethality of rip1−/−rip3−/−tnfr−/− mice
also suggests a key role for FADD/caspase 8-mediated apoptosis
in RIP1 perinatal lethality. Therefore, lethality of RIP1 knockout
mice is due to multiple factors.
Thymocytes isolated from DKO and TKO mice were resis-
tant to death induced by the extrinsic pathways triggered through
stimulations with anti-Fas antibodies or TNFα (Figures 5A,B).
However, these mutant T cells were sensitive to cell death induced
by dexamethasone, staurosporine, or ionomycin, similar to that
of the wild-type control mice (Figures 5C,D,E). Extrinsic cell
death has been shown to play a key role in lymphocyte home-
ostasis and peripheral tolerance (Strasser et al., 2009). When
lymphocytes are not capable of being eliminated in the periph-
ery, progressive accumulation of lymphocytes can occur in the
peripheral lymphoid organs. This is the case in lpr mice, display-
ing splenomegaly and lymphadenopathy as a result of a mutation
in the Fas gene. Whereas disruption of the FADD function alone
through gene deletion or using FADD-DN results in a lym-
phopenic condition (Newton et al., 1998; Walsh et al., 1998;
Zhang et al., 2005), double deletion of both FADD and RIP3 leads
to lpr-like symptoms (Figures 7, 8), which is similar to that in
caspase8−/−rip3−/− mice (Kaiser et al., 2011; Oberst et al., 2011),
but is more severe that in fas−/− mutant mice. Notably, however,
a diminished lpr disease was present in rip1−/−fadd−/−rip3−/−
mice (Figures 7, 8). This indicates that RIP1 has additional
functions besides blocking FADD-mediated apoptosis and RIP3-
dependent necroptosis. Interestingly, rip1−/−fadd−/−rip3+/−
mice develop splenomegaly, but not lymphadenopathy, after sev-
eral months of age (data not shown), indicating a role for RIP3-
dependent necroptosis in the clearance of lymphocytes in the
lymph nodes, but not the spleen. These rip1−/−fadd−/−rip3+/−,
as well as DKO and TKO mice, contain varying numbers of
the peculiar CD3+B220+ T cells, which lose CD4 and CD8
expression (Figure 8 and data not shown). These data, in total,
illustrate that in the immune system, chronic activation of lym-
phocytes disrupts homeostasis and leads to autoimmunity, which
can be prevented by FADD-mediated apoptosis, a sterile PCD.
RIP3-deficient T cells undergo normal activation-induced cell
death (AICD), indicating that FADD-mediated apoptosis is suf-
ficient for maintaining homeostasis. Intuitively, apoptosis is a
preferred pathway for AICD as necroptosis may potentially lead to
inflammation which needs to be suppressed by FADD. Therefore,
although pro-inflammatory, RIP1/RIP3-dependent necroptosis
serves as a backup, when the FADD pathway is compromised. It
is interesting to note that there appeared to be more cell divi-
sion in activated fadd−/−rip3−/− T cells than in wild type T
cells (Figure 6). This may due in part to decreased cell death
in activated fadd−/−rip3−/− T cells, and/or a role for FADD
in negatively regulating T cell proliferative responses. As such,
both of these functions of FADD likely contribute to the greatly
accelerated lpr disease in fadd−/−rip3−/− mice.
Clearly, RIP1 plays an essential role in the life of an organ-
ism and the absence of this protein can only be compensated
for by removing both apoptosis and necroptosis pathways. Due
to its essential function of regulating not only cell death, but
also cell survival, there may be further important consequences
for the loss of such a key protein. Future investigations will
drive the discoveries of the essential functions of RIP1 and the
consequences for deleting RIP1. These studies will broaden our
understanding of RIP1 function and could lead to the develop-
ment of new strategies to target inflammatory conditions as well
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as cancer and autoimmune diseases, that may be exacerbated due
to unregulated necrosis.
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